Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 26(32): 4730-7, 2007 Jul 12.
Article in English | MEDLINE | ID: mdl-17297452

ABSTRACT

Asbestos is a pulmonary carcinogen known to give rise to DNA and chromosomal damage, but the exact carcinogenic mechanisms are still largely unknown. In this study, gene expression arrays were performed on lung tumor samples from 14 heavily asbestos-exposed and 14 non-exposed patients matched for other characteristics. Using a two-step statistical analysis, 47 genes were revealed that could differentiate the tumors of asbestos-exposed from those of non-exposed patients. To identify asbestos-associated regions with DNA copy number and expressional changes, the gene expression data were combined with comparative genomic hybridization microarray data. As a result, a combinatory profile of DNA copy number aberrations and expressional changes significantly associated with asbestos exposure was obtained. Asbestos-related areas were detected in 2p21-p16.3, 3p21.31, 5q35.2-q35.3, 16p13.3, 19p13.3-p13.1 and 22q12.3-q13.1. The most prominent of these, 19p13, was further characterized by microsatellite analysis in 62 patients for the differences in allelic imbalance (AI) between the two groups of lung tumors. 79% of the exposed and 45% of the non-exposed patients (P=0.008) were found to be carriers of AI in their lung tumors. In the exposed group, AI in 19p was prevalent regardless of the histological tumor type. In adenocarcinomas, AI in 19p appeared to occur independently of the asbestos exposure.


Subject(s)
Adenocarcinoma/chemically induced , Allelic Imbalance , Asbestos/toxicity , Carcinogens/toxicity , Chromosomes, Human, Pair 19/genetics , Lung Neoplasms/chemically induced , Occupational Exposure , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Female , Gene Dosage , Gene Expression Profiling , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Male , Microsatellite Repeats/genetics , Middle Aged
2.
J Pathol ; 209(2): 206-12, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16521118

ABSTRACT

High mobility group A (HMGA) proteins play an important role in the regulation of transcription, differentiation, and neoplastic transformation. In this work, the expression of HMGA 1 and 2 in 152 lung carcinomas of mainly non-small-cell histological type has been studied by immunohistochemistry in order to evaluate their feasibility as lung cancer markers. In 17 lung cancer cases, the related bronchial epithelial changes were also studied for HMGA1 and 2 expression. RNA expression of HMGA1a and b isoforms and of HMGA2 was determined by real-time semi-quantitative RT-PCR in 23 lung carcinomas. High expression of HMGA1 and HMGA2 at both mRNA and protein levels was detected in lung carcinomas, compared with normal lung tissue. Nuclear immunostaining for HMGA1 and 2 proteins also occurred in hyperplastic, metaplastic, and dysplastic bronchial epithelium. Increased nuclear expression of HMGA1 and 2 correlated with poor survival (for adenocarcinomas, HMGA1, p=0.006; HMGA2, p=0.05). While the expression of HMGA2 was significantly associated with cell proliferation (p=0.008), HMGA1 expression did not show any association with proliferation or apoptotic index. Sequencing of HMGA2 transcripts from tumours with very high expression showed a normal full-length transcript. As HMGA proteins were expressed in about 90% of lung carcinomas and their expression was inversely associated with survival, they may provide useful markers for lung cancer diagnosis and prognosis.


Subject(s)
Carcinoma/chemistry , HMGA Proteins/analysis , Lung Neoplasms/chemistry , Neoplasm Proteins/analysis , Aged , Apoptosis/physiology , Carcinoma/pathology , Carcinoma, Non-Small-Cell Lung/chemistry , Carcinoma, Non-Small-Cell Lung/pathology , Cell Division/physiology , Female , HMGA1a Protein/analysis , HMGA1b Protein/analysis , HMGA2 Protein/analysis , Humans , Immunohistochemistry/methods , Lung Neoplasms/pathology , Male , Middle Aged , Prognosis , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Tissue Array Analysis/methods
3.
Am J Hum Genet ; 68(2): 509-14, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11133359

ABSTRACT

Congenital cataract is a clinically and genetically highly heterogeneous eye disorder, with autosomal dominant inheritance being most common. We investigated a large seven-generation family with 74 individuals affected by autosomal dominant congenital cataract (ADCC). The phenotype in this family can be described as "central pouchlike" cataract with sutural opacities, and it differs from the other mapped cataracts. We performed linkage analysis with microsatellite markers in this family and excluded the known candidate genes. A genomewide search revealed linkage to markers on chromosome 15, with a maximum two-point LOD score of 5.98 at straight theta=0 with marker D15S117. Multipoint analysis also gave a maximum LOD score of 5.98 at D15S117. Multipoint and haplotype analysis narrowed the cataract locus to a 10-cM region between markers D15S209 and D15S1036, closely linked to marker D15S117 in q21-q22 region of chromosome 15. This is the first report of a gene for a clinically new type of ADCC at 15q21-22 locus.


Subject(s)
Cataract/genetics , Chromosomes, Human, Pair 15/genetics , Cataract/congenital , Cataract/pathology , Chromosome Mapping , Family Health , Female , Genetic Linkage , Haplotypes , Humans , Lod Score , Male , Microsatellite Repeats , Molecular Sequence Data , Pedigree
SELECTION OF CITATIONS
SEARCH DETAIL
...